Survey of Bladder Cancer Patients Reveals Big Changes – Patients are Looking for Cysview® (hexaminolevulinate) published the key results of a survey answered by 600 bladder cancer patients. The biggest take-aways were that, more than ever before, bladder cancer patients know about Blue Light Cystoscopy with Cysview and are selecting urologists and treatment facilities that offer it.

Read the full story.